Diabetes Kongress 2020
Kalender
Liste
Personen
Favoriten
zur Liste
Dr. Sebastian Pieperhoff
Novo Nordisk Pharma GmbH
Germany
Vortrag
Efficacy of Semaglutide by Background Sodium–glucose Co-transporter-2 Inhibitor: a Post Hoc Analysis of SUSTAIN 9
Speaker
Datum: 21.05.2020 , Zeit: 16:14
|
Thema: Poster
Details
Vortrag
Efficacy and Safety of Semaglutide by Baseline BMI in SUSTAIN 1–5 and 7
Speaker
Datum: 21.05.2020 , Zeit: 16:21
|
Thema: Poster
Details